Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predicting human pharmacokinetics from preclinical data.

Italo Poggesi1

  • 1Pharmacia Italia SpA, Pfizer group Inc., Prediction and Modeling Pharmacokinetics, Dynamics and Metabolism Via Pasteur 10, 20014 Nerviano (MI), Italy. italo.poggesi@pharmacia.com

Current Opinion in Drug Discovery & Development
|February 26, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Genetic Algorithm-Based Approach for Quantitative Prediction of Drug-Drug Interactions Caused by Cytochrome P450 3A Inhibition or Induction in Horses.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Development of an Empirical Approach for the Prediction of Cytochrome P450-Based Drug-Drug Interactions in Pediatric Patients.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

A Randomized Trial on the Combined Effect of Ponesimod and Propranolol on Heart Rate, Cardiac Safety, and Pharmacokinetics in Healthy Adults.

Clinical and translational science·2025
Same author

A genetic algorithm-based approach for quantitative prediction of drug-drug interactions caused by cytochrome P450 3A inhibitors and inducers in dogs and cats.

Chemico-biological interactions·2025
Same author

A genetic algorithm-based approach for the prediction of metabolic drug-drug interactions involving CYP2C8 or CYP2B6.

Journal of pharmacological and toxicological methods·2024
Same author

Pharmacokinetics of intranasal drugs, still a missed opportunity?

Xenobiotica; the fate of foreign compounds in biological systems·2024
Same journal

Microreactors for continuous processing – How close to commercial utility?

Current opinion in drug discovery & development·2010
Same journal

Synthesis of polyketide natural products and analogs as promising anticancer agents.

Current opinion in drug discovery & development·2010
Same journal

Enantioselective synthesis of substituted oxindoles and spirooxindoles with applications in drug discovery.

Current opinion in drug discovery & development·2010
Same journal

Eliminating pharmaceutical impurities: Recent advances in detection techniques.

Current opinion in drug discovery & development·2010
Same journal

Stereoselective heterocycle synthesis through oxidative carbon-hydrogen bond activation.

Current opinion in drug discovery & development·2010
Same journal

Catalysis in aqueous media for the synthesis of drug-like molecules.

Current opinion in drug discovery & development·2010
See all related articles

Predicting human pharmacokinetics often uses animal data, but in vitro and in silico methods are improving accuracy. Integrating diverse data sources is key for precise pharmacokinetic predictions and understanding ADME processes.

Area of Science:

  • Pharmacology
  • Drug Development
  • Computational Biology

Background:

  • Current human pharmacokinetic (PK) predictions primarily use animal in vivo data via allometric scaling or time-invariant methods.
  • In vitro and in silico screening tools are increasingly utilized for pharmaceutical, pharmacokinetic, and toxicity assessments.

Purpose of the Study:

  • To evaluate the predictive capabilities of existing and emerging methods for human pharmacokinetics.
  • To highlight the need for integrating diverse data sources for enhanced PK prediction accuracy.

Main Methods:

  • Review of established methods: allometric scaling and time-invariant models using animal in vivo data.
  • Assessment of in vitro and in silico screening approaches for predicting drug behavior in humans.
  • Discussion on data integration strategies.

Related Experiment Videos

Main Results:

  • Existing methods, when applied judiciously, typically achieve pharmacokinetic parameter predictions within a 2- to 3-fold range of observed human values.
  • In vitro and in silico methods offer complementary data for predicting complex in vivo human behavior.

Conclusions:

  • Integrating information from various sources (in vivo, in vitro, in silico) is crucial for improving the precision and accuracy of pharmacokinetic predictions.
  • Enhanced PK predictions will lead to a better understanding of Absorption, Distribution, Metabolism, and Excretion (ADME) processes in humans.